Latest publications
CAR T cell therapy selectively depletes disease-driving mutant calreticulin cells in xenotransplants and human organoid models of myelofibrosis.
Journal article
Rampotas A. et al, (2026), Sci Transl Med, 18
TiO2 Alternative Coatings for Ferric Pyrophosphate Premixes: Stability and Bioaccessibility Relative to Ferrous Fumarate
Journal article
Teichman DL. et al, (2026), Innovative Food Science and Emerging Technologies, 111
TRANSFORM-1 Phase 3 study: Efficacy and safety of navitoclax plus ruxolitinib in patients with untreated myelofibrosis.
Journal article
Pemmaraju N. et al, (2026), Blood
ChatMDV: Reducing Technical Barriers in Bioinformatics Analysis using Large Language Models.
Journal article
Kiourlappou M. et al, (2026), Gigascience
Development of a recombinant single-cycle influenza viral vector as an intranasal vaccine against SARS-CoV-2.
Journal article
Munro J. et al, (2026), Sci Rep
Upcoming Seminars
Deciphering the gene regulation of oxygen homeostasis and human fitness through the lens of erythropoietin producing Norn cells
Tuesday, 07 July 2026, 2.30pm to 3.30pm
Speaker(s): Bjørt Katrinardóttir Kragesteen (Karolinska Institutet)
Series: Molecular Haematology Unit, WIMM
Status: Cancelled
TBC
Tuesday, 01 September 2026, 1pm to 2pm
Speaker(s): Akhihiko Yokoyama
Series: Molecular Haematology Unit
Therapeutic targeting of epigenetic enzymes in haematological malignancies
Tuesday, 22 September 2026, 1pm to 2pm
Speaker(s): Professor Tim Somervaille
Series: Molecular Haematology Unit, WIMM
TBC
Tuesday, 06 October 2026, 1pm to 2pm
Speaker(s): Inigo Martincorena (Wellcome Sanger Institute)
Series: Molecular Haematology Seminar Series


